Lilly inks obesity deal with seed-stage RNA startup as its genetic medicines effort enters the spotlight

Eli Lilly is pairing up with a so-called “dark genome” biotech startup to hunt for a new generation of obesity and metabolic drugs.

The Indianapolis …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Precision unveiled: Exploring the cutting-edge of analytical weighing with Cubis® II ultra-high resolution balances

This interview explores the cutting edge of analytical weighting with Cubis® II ultra-high resolution balances.

March 20, 2024

Sunstone Therapies in Collaboration with the University of Vermont Announces Publication of Study Showing Feasibility of Direct Observation of Therapeutic Connection in Psilocybin-Assisted Therapy | Psychedelic Invest

Sunstone Therapies in Collaboration with the University of Vermont Announces Publication of Study Showing Feasibility of Direct Observation of Therapeutic Connection in Psilocybin-Assisted Therapy Study

August 25, 2023

Kaiser Permanente to Deploy Innovaccer’s Healthcare AI Platform

What You Should Know: – Innovaccer, a leading healthcare technology company, today announced its collaboration with Kaiser Permanente, America’s leading healthcare provider and nonprofit health

April 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.